Seminars in Nephrology
Volume 26, Issue 2 , Pages 95-104, March 2006

Lupus Nephritis

  • Neerja Agrawal
  • ,
  • Lo-Ku Chiang
  • ,
  • Ian R. Rifkin

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr. Ian R. Rifkin, Renal Section, Department of Medicine, Boston University School of Medicine, EBRC 5th Floor, 650 Albany St, Boston, MA 02118.

Department of Medicine, Boston University School of Medicine, Boston, MA.

Lupus nephritis is one of the more serious manifestations of the systemic autoimmune disease, systemic lupus erythematosus, and is associated with considerable morbidity and even mortality. Treatment remains problematic, particularly in terms of controlling the underlying disease process while at the same time preventing unacceptable side effects of therapy. In recent years, clinical trials have started to define optimum regimens of the immunosuppressive agents presently in use. The etiology and pathogenesis of systemic lupus erythematosus and lupus nephritis still are understood incompletely. Nevertheless, insights gained from basic science research in both animals and human beings now are being translated into newer therapies that have the potential to be safer and more specific than those currently available.

Keywords:  lupus , nephritis , autoimmunity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants from the National Institutes of Health (DK02597 and AR050256), the National Kidney Foundation, and the Lupus Research Institute (I.R.R.).

PII: S0270-9295(05)00183-X

doi:10.1016/j.semnephrol.2005.09.002

Seminars in Nephrology
Volume 26, Issue 2 , Pages 95-104, March 2006